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pen accessAbstract Introduction: Patient controlled analgesia (PCA) provides a better analgesia over conven-
tional opioid treatment. The reduction of bolus size and its efﬁcacy on pain relief and associated side
effects were not enormously studied. This study was constructed to evaluate small versus traditional
bolus size PCA, including pain relief, and side effects of both regimens.
Methods: Seventy-seven patients were included in the study. All patients received general anesthesia.
Patients were randomly distributed between two groups; traditional group (M1) received a bolus dose
of Morphine as 0.02 mg/kg body weight to a maximum of 1.5 mg, and group (M2) where 0.01 mg/kg
body weight to a maximum of 0.75 mg is the bolus dose. PCA machines were set up at 6 min lockout
interval and a maximum dose of 0.15 mg/kg/h to a maximum of 10 mg/h. Rescue doses were given
according to pain scores and reported. 1000 mg Paracetamol every 6 h were given. Morphine con-
sumption at 24 and 48 h, VAS at 1, 2 then every 4 h for 48 h were measured. Reported complications
as respiratory depression, over sedation, constipation, pruritus, nausea and vomiting were analyzed.
Results: Morphine consumption in small bolus size group M2 during the ﬁrst (36.38 ± 17.75) and
second 24 h (30.22 ± 17.15) were less when compared to large bolus size group M1 (39.20 ± 17.971065574.
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80 Y. Ali Hammad et al.and 36.38 ± 17.75), the change was insigniﬁcant. In spite of using small bolus sizeMorphine in group
M2, pain scores were close to groupM1 and statistically insigniﬁcant. The frequency of occurrence of
side effects was statistically insigniﬁcant when comparing the two groups.
Conclusions: Small bolus size of Morphine PCA produces efﬁcient pain relief but does not reduce
total morphine consumption nor did morphine associate side effects.
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Systemic use of opioids for control of pain following orthope-
dic surgery is common and a meta-analysis results show that
patient controlled analgesia (PCA) provides a better analgesia
than conventional opioid treatment [1]. Combined use of par-
acetamol and morphine for treatment of postoperative pain
has been studied before in certain procedures. In some studies
this combined regimen can reduce the total dose of analgesics
and minimize the adverse effects, however in other studies,
morphine sparing effect did not result in parallel reductions
in opioid-related adverse effects [2–4] or narcotic requirements.
Respiratory depression and other opioids side effects like nau-
sea, vomiting and pruritus are a major concern of PCA usage.
Some major studies including over 10,000 patients suggested
signiﬁcant PCA associated respiratory depression requiring
intervention, to occur in a range of 0.2% [5]. Respiratory
depression and other opioids side effects were related to the
total consumption. Few studies were published about reduc-
tion of bolus size and its efﬁcacy on pain relief and associated
side effects; the results were incorporate [6,7]. In the present
study the investigators hypothesized that perioperative com-
bined use of intravenous paracetamol and PCA morphine
may result in decreasing the bolus size and hence opioid asso-
ciated side effects. The primary aim of this study is to study
pain relief using small versus traditional large bolus size
PCA. The secondary aim is to study and compare between side
effects of both regimens.
2. Methods
After informed patient consenting, minimum of 72 patients
scheduled for abdominal surgeries with skin incision – 15 cm
and total hip or knee replacement, were included in a random-
ized, single-blinded, placebo-controlled study.
The sample size is based on other study [6], comparing the
change in morphine consumption between the two groups, a
power of 0.80, signiﬁcance criterion of <0.05, estimated stan-
dard deviation of 10 and a minimum expected difference of 50.
Patients on any opioids, less than 18 year or more than 60 year
old and who are allergic to Morphine or Paracetamol were ex-
cluded from the study.
All patients received general anesthesia with Propofol 2 mg/
kg and fentanyl 2 mcg/kg at induction, and maintained on
Sevoﬂurane and fentanyl infusion 2 mcg/kg/min. In PACU,
rescue doses of Morphine (0.2 mg/kg) were used divided on
four doses every 6 min until pain is controlled and VAS below
3. Patients were randomly distributed between two groups
using computer program, traditional group (M1) where pa-
tients received a bolus dose of Morphine as 0.02 mg/kg body
weight to a maximum of 1.5 mg using PCA machine and
0.01 mg/kg body weight to a maximum of 0.75 mg in small dosegroup (M2) [8]. Patients started using PCA machine CAD
Solis, USA, with a computerized self reporting system before
discharging from PACU at 6 min lockout interval and a maxi-
mum dose of 0.15 mg/kg/h to a maximum of 10 mg/h. All pa-
tients have a patent intravenous line with crystalloids running
at 50–100 ml/h and monitored by continuous pulse oximetry.
PCA bolus dose was increased by 0.5 mg at anytime to a
maximum of 2 mg, if pain was persistent with VAS more than
4 and after 2 rescue doses of 2.5 mg Morphine using the PCA
machine. This was done by acute pain service (APS) physician
who was blinded to the study and according to APS and hospi-
tal policy. Respiratory depression with oxygen saturation less
than 90% and/or over sedation are treated with intravenous
Naloxon 0.4 mg in divided doses when required together with
decreasing the PCA bolus dose by 0.5 mg. All patients received
regular doses of 1000 mg Paracetamol every 6 h starting 15 min
before skin closure and a prophylactic dose of grainsetron 1 mg
for nausea and/or vomiting. Measurements included total Mor-
phine consumption in 24 h and 48 h, VAS after 1, 2 then every
4 h for 48 h. Complications as respiratory depression deﬁned as
oxygen saturation less than 90%, over sedation (Ramsay seda-
tion score more than 3) [9], constipation, pruritus, nausea and
vomiting were recorded. Measurements will be recorded via
PCA machine CAD Solis, USA, with a computerized self
reporting system and reported by a blind observer.
3. Results
Seventy-seven patients were included in the study after exclud-
ing 4 patients due to missing data. 40 patients were included in
traditional (M1) group, and 37 patients in small dose (M2)
group. Table 1 reﬂects changes in the demographic data where
there were no signiﬁcant changes between the two studied
groups in age, sex, body weight and surgical procedures.
Nevertheless the consumption of Morphine in small bolus
size group M2 during the ﬁrst (36.38 ± 17.75) and second
24 h (30.22 ± 17.15) were less when compared to large bolus
size group M1 (39.20 ± 17.97 and 36.38 ± 17.75), the change
was insigniﬁcant (Table 2).
In spite of using small bolus size Morphine in group M2,
pain scores were close to group M1 and statistically insigniﬁ-
cant (Fig. 1).
Table 3 represents the frequency of occurrence of side
effects which were statistically insigniﬁcant when comparing
the two groups by using Fisher exact test.
4. Discussion
In the present study, the use of small bolus dose has lead to
efﬁcient pain relief with less but insigniﬁcant decrease in
Morphine consumption. The side effects were close and statis-
tically insigniﬁcant between the two studied groups.
Table 1 Demographic data.
Group M1 (n= 40) Group M2 (n= 37)
Age 41.03 ± 16.19 44.05 ± 18.89
Weight 79.18 ± 12.60 78.43 ± 11.53
Sex F/M 18/22 22/15
Abdominal surgery 20 19
Total hip replacement 11 10
Total knee replacement 9 8
Values are mean ± standard deviation.
Group M1 = patients receiving large bolus dose of PCA morphine.
Group M2 = patients receiving small bolus dose of PCA morphine.
Figure 1 Pain assessment at 1, 4, 8, 12, 18 and 24 h by visual
analogue scale (0 = no pain, 10 = severe pain) between group M1
(control) and group M2 (cases).
Table 3 The frequency of side effects.
Group M1 (n= 40)
Sedation 1 (2.5%)
Respiratory depression 0
Constipation 0
Pruritus 2 (5%)
N and V 8 (20%)
*p Values < 0.05 are considered signiﬁcant.
Results are expressed as number (%).
Group M1 = patients receiving large bolus dose of PCA morphine.
Group M2 = patients receiving small bolus dose of PCA morphine.
Table 2 Bolus dose and Morphine consumption (mg) at 24, 48 h.
Group M1 (n= 40) Group M2 (n= 37) t-Test (p) Group M1 paired
t (each two consecutive) (p)
Group M2 paired
t (each two consecutive) (p)
Bolus dose 1.27 ± 0.34 0.73 ± 0.16 8.79* (<0.001)
Morph
24 h
39.20 ± 17.97 33.46 ± 18.23 1.39 (0.168)
Morph
48 h*
36.38 ± 17.75 30.22 ± 17.15 1.53 (0.130) 6.46* (<0.001) 8.03* (<0.001)
Results are expressed as mean ± SD.
Group M1 = patients receiving large bolus dose of PCA morphine.
Group M2 = patients receiving small bolus dose of PCA morphine.
* p values < 0.05 are considered signiﬁcant.
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postoperative pain can be used for the assessment and compar-
ison of pain relief effect of analgesics. PCA allows patients to
titrate the dose of analgesic needed for adequate pain relief by
themselves. In addition, the numbers of attempts are used for
assessment of proper analgesia.
In the present study, the efﬁcacy of analgesia was not as-
sessed by the number of missed attempts since PCA machine
CAD Solis, USA, handles are supported with green light to
indicate the readiness for ﬁring and a red light indicating that
the machine is in lockout period.
Pain relief efﬁcacy was assessed by VAS which was efﬁcient
in the two studied groups (Fig. 1) with insigniﬁcant difference.
This adequate analgesia in spite of using reduced bolus size in
group M2 (0.73 ± 0, 16 vs. 1.27 ± 0.33 mg) is interesting.
Low pain scores in group M2 with small bolus Morphine
can be explained by analyzing total Morphine consumption
in the ﬁrst and second 24 h. The consumption was less in groupGroup M2 (n= 37) p value
2 (5.4%) 0.605
1 (2.7%) 0.481
1 (2.7%) 0.481
0 0.494
6 (16.2%) 0.771
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studied groups (39.2 ± 17.9 vs. 33.4 ± 18.2 mg) in the ﬁrst
24 h and (36.4 ± 17.7 vs. 30.22 ± 17.15) after 48 h.
The results go with the study done by Morlion et al. [6]
when the authors used a reduced bolus size of patient
controlled analgesia; there were no signiﬁcant decrease total
consumption or side effects.
From other studies we know that Paracetamol is an effec-
tive adjunct to opioid analgesia, opioid requirements being re-
duced by 20–30% when combined with a regular regimen of
oral or rectal paracetamol [10]. The use of oral paracetamol
in higher daily doses (1 g every 4 h) in addition to PCA mor-
phine lowered pain scores, shortened the duration of PCA
use and improved patient satisfaction [11]. Meta-analyses
looking at paracetamol as an adjunct to PCA opioids also
showed that PCA morphine requirements were decreased but
there was no improvement in pain relief or decrease in
opioid-related adverse effects [4,12]. In the present study,
Paracetamol was used as adjuvant drug to Morphine in order
to decrease the total Morphine requirements.
When studying PCA associated side effects, no patients re-
quired mechanical ventilation because of excessive respiratory
depression and persistent low oxygen saturation. Inspite of the
small bolus size in group M2, one patient had oxygen satura-
tion less than 90% and treated with oxygen and 0.2 mg
Naloxon; this change was statistically insigniﬁcant when
compared to patients in group M1.
However, the number of patients with a peripheral oxygen
saturation below 90% varied somewhat between the studies;
the variation may simply be a result of different timetables
for the measurements in each study. In a Clinical study
including a large sample size of over 10,000 patients, the inci-
dence of signiﬁcant respiratory depression requiring interven-
tion was 0.2% [5] and 1.2–11.5% in Dolin and Cushman
study [13].
Postoperative nausea and vomiting is one of the most fre-
quent complications after pain in the postoperative period.
The incidence in the present study varied from 19.5% in group
M1 to 15.8% in group M2. No signiﬁcant reduction in postop-
erative nausea and vomiting was seen between the two studied
groups.
Dolin and Cashman in their review of patient tolerability to
PCA, suggested that there may be differences in the clinical
setting and they reported means for complications following
PCA: nausea 32%, vomiting 20.7%, pruritus 13.8% and
excessive sedation 5.3% [13].
5. Conclusions
Small bolus size of Morphine patient controlled analgesia pro-
duces efﬁcient pain relief but does not reduce total morphine
consumption or morphine associate side effects.
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